Delivery Order SPE2DR25D3202-SPE2DR26F8E7S
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,588.72 to AmerisourceBergen Drug Corp for the supply of Azathioprine 50 mg tablets (100-count units) on January 7, 2026, with an ultimate completion date of January 8, 2026. This is a firm fixed-price, non-set-aside competitive award to be performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,591.77 to AmerisourceBergen Drug Corp for the supply of Azathioprine 50 mg tablets (100-count units). This competitive contract award, finalized on December 8, 2025, with an ultimate completion date of December 9, 2025, represents a firm fixed-price delivery order with no set-aside designation. The performance location is identified as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order valued at $1,655.63 to AmerisourceBergen Drug Corp for the supply of Azathioprine 50 mg tablets (100 count) on August 13, 2025, with completion expected by August 14, 2025. This non-competitive, firm fixed-price delivery order was issued under a child contract mechanism and represents a routine pharmaceutical procurement for federal medical supply needs. The place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 100 tablets of Azathioprine 50 mg, a firm fixed price contract valued at $2,022.10. The order was competitively awarded without set-aside designation and has an ultimate completion date of December 22, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Azathioprine 50 mg tablets (100 count) under a firm fixed-price contract valued at $2,321.22, with a completion date of December 11, 2025. This non-set-aside award was competitively procured and represents a routine pharmaceutical supply transaction to support federal medical needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Azathioprine 50 mg tablets (100-count units) under a firm fixed price contract valued at $2,091.28. This non-set-aside, competitively awarded delivery order is scheduled for completion by December 5, 2025, with performance to take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Azathioprine 50 mg tablets (100 count) under a firm fixed-price contract type with no set-aside designation. The award, issued on December 8, 2025, carries a ceiling value of $5,064.48 and an ultimate completion date of December 9, 2025. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate office. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,187.99 to AmerisourceBergen Drug Corp for the supply of Azathioprine 50 mg tablets (100-count units) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price, non-set-aside contract is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Azathioprine 100 mg tablets (100-count units) with a ceiling value of $1,794.82. This non-competitive, firm fixed-price delivery order, issued on November 17, 2025, is set to conclude by November 18, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Azathioprine 50 mg tablets in quantities of 100 units. This contract, valued at $3,126.34 with a firm fixed price structure, represents a non-set-aside competitive award and is scheduled for completion by December 8, 2025. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters and...
- SPE2DR25D3202Indefinite Delivery Contract
- SPE2DR25D3202-SPE2DR26F8E7SDelivery Order
The Defense Logistics Agency has awarded a delivery order valued at $2,022.10 to AmerisourceBergen Drug Corp for the supply of Azathioprine 50 mg tablets in quantities of 100 units. This non-competitive delivery order carries a firm fixed-price structure with an ultimate completion date of January 26, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026. This comprehensive IDC enables the contractor to supply a broad range of pharmaceutical products and medical supplies globally to support military healthcare programs, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. The contract reflects DLA's strategic approach to pharmaceutical procurement through prime vendor agreements that leverage qualified distributors' capabilities to meet the diverse medical needs of the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 1/22/26 |